Asher Chanan-Khan - Jun 30, 2021 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Director
Signature
/s/ Christina Blakley, attorney-in-fact for Asher Chanan-Khan
Stock symbol
CLRB
Transactions as of
Jun 30, 2021
Transactions value $
$0
Form type
4
Date filed
7/2/2021, 04:02 PM
Previous filing
Jul 2, 2021
Next filing
Aug 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +78K $0.00 78K Jun 30, 2021 Common Stock 78K $1.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock option vest in equal annual increments on June 30, 2022, June 30, 2023, and June 30, 2024.